CLINICAL OUTCOMES OF POSTERIOR FOSSA TUMOR SURGERY WITHOUT PREOPERATIVE VENTRICULAR-PERITONEAL SHUNT

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 7

Abstract

The aim of the study was to assess the clinical outcome of surgically treated patients with posterior fossa tumor with hydrocephalus with symptoms and signs of raised intracranial pressure without pre-operative ventriculo-peritoneal shunt by comparing two groups (one group-with pre-operative ventriculo-peritoneal shunt and other group-without preoperative ventriculo-peritoneal shunt) in respect to complications, duration of hospital stay and final outcome at 1 month post-operative follow up. This clinical study was carried out at the department of neurosurgery, BSMMU from November 2008 to April 2010 on patients with posterior fossa tumor with hydrocephalus with symptoms and signs of raised intracranial pressure (ICP) who underwent surgery without preoperative ventriculo-peritoneal shunt. A total of 32 patients were included in this study. Patients were divided into two groups, control group (group-A) underwent ventriculo peritoneal shunt prior to tumor surgery and experimental group (group-B) were not treated with ventriculo-peritoneal shunt prior to tumor surgery. Both groups were followed up during hospital stay and after 1 month of tumor resection. Clinical studies include analysis of the following parameters: i) duration of hospital stay, ii) post-operative complications include cerebrospinal fluid leakage, pseudomeningocele, seizure, meningitis, and shunt blockage and, iii) final outcome at 1 month follow up in modified karnofsky performance scale. We also observed whether or not, use of ventriculo-peritoneal shunt to drain cerebrospinal fluid was useful and safe. The mean duration of hospital stay were 95.1±12.6 days with ranged from 70 to 120 days and 71.5±12.6 days ranged from 36 to 88 days in group-A and group-B respectively. The majority of the patients had no complications in both group, which were 12(70.6%) and 9 (60.0%) in group A and group B respectively. Final outcome at 1 month follow up in modified karnofsky performance scale in both groups were similar.

Authors and Affiliations

Rafiqul Islam

Keywords

Related Articles

FREQUENCY OF BORRELIA BURGDORFERI WESTERN BLOT AND LTT POSITIVITY AMONG MULTIPLE SCLEROSIS PATIENTS FROM TURKEY

In Turkey, Borrelia burgdorferi infections are not well known among physicians and almost completely overlooked. On the other hand, a small number of seropositivity studies (%3.3-%73) show that Borrelia burgdorferi is co...

EVALUATION OF TUBERCULOSIS DISEASE AWARENESS AND UNDERSTANDING AMONGST PHARMACY STUDENTS AT THE UNIVERSITY OF WOLVERHAMPTON

Introduction: Tuberculosis (TB) caused by the bacterium Mycobacterium tuberculosis is recognised as the leading cause of death due to infectious disease in the world. Pharmacies and pharmacy workers, together with GPs an...

AICARDI SYNDROME: CASE REPORT

Aicardi syndrome is a congenital disorder characterized by severe psychomotor retardation, corpus callosum agenesis, chorioretinal lacunae, and early-onset infantile spasms. The prognosis is generally poor for children w...

CROSSED TESTICULAR ECTOPIA: REPORT OF TWO CASES

Crossed testicular ectopia also called transverse testicular ectopia (TTE) is very rare congenital anomaly in which one testis migrate to the opposite hemiscrotum. Unlike the undescended testis, which occurs in approxima...

IN VITRO AMOEBICIDAL ACTIVITY OF AQUEOUS EXTRACTS AND THEIR FRACTIONS FROM SOME MEDICINAL PLANTS USED IN TRADITIONAL MEDICINE AS ANTIDIARRHEAL AGENTS IN KINSHASA-DEMOCRATIC REPUBLIC OF CONGO AGAINST ENTAMOEBA HISTOLYTICA

40 aqueous extracts and 126 fractions obtained from the partition of these aqueous extracts were submitted to an assessment in vitro for their potential amoebicidal activity against Entamoeba histolytica. Results reveale...

Download PDF file
  • EP ID EP636191
  • DOI -
  • Views 130
  • Downloads 0

How To Cite

Rafiqul Islam (2018). CLINICAL OUTCOMES OF POSTERIOR FOSSA TUMOR SURGERY WITHOUT PREOPERATIVE VENTRICULAR-PERITONEAL SHUNT. European Journal of Biomedical and Pharmaceutical Sciences, 5(7), 23-27. https://europub.co.uk/articles/-A-636191